A. Meguid El Nahas - Concepedia

Author

A. Meguid El Nahas

Also Known As

A M EL Nahas, A M El Nahas, A M el Nahas, A Meguid El Nahas, A Nahas, A. M. El Nahas, A. M. Nahas, A. M. el Nahas, A. MEGUID EL NAHAS, A. Meguid EL NAHAS

126

Publications

6.5K

Citations

H-Index

Concepts

All Affiliations

Sheffield Kidney Institute Northern General Hospital University of Sheffield Nottingham Trent University Sheffield Teaching Hospitals NHS Foundation Trust

About

A. Meguid El Nahas is an author at Sheffield Kidney Institute specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	27	36	2.7K
2	Biochemistry	5	5	331
3	Natural Sciences	2	2	131
4	Public Health	2	2	74
5	Health Sciences	1	1	108

A. Meguid El Nahas

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
The Outcome of Acute Renal Failure in the Intensive Care Unit According to RIFLE: Model Application, Sensitivity, and Predictability Nihal Y. Abosaif, Yasser Tolba, Mike Heap, American Journal of Kidney Diseases Critical Care ManagementAcute Renal FailureIntensive Care UnitMedicineKidney Failure	2005	311
Prevention of chronic kidney disease: A global challenge Aminu K. Bello, Emeka Nwankwo, A. Meguid El Nahas Kidney International GlomerulonephritisRenal DiseaseMedicineGlobal HealthKidney Failure	2005	216
Role of growth hormone in the development of experimental renal scarring A. Meguid El Nahas, A. H. Bassett, Geoff H. Cope, Kidney International UrologyDevelopmental BiologyRenal FunctionGrowth HormoneHuman Growth	1991	156
Interferon-γ inhibits experimental renal fibrosis S. Oldroyd, Graham L. Thomas, Giulio Gabbiani, Kidney International InflammationGlomerulonephritisUrologyFibrosisRenal Pathology	1999	149
Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Colin B. Brown, J R Shortland, A. Meguid El Nahas Nephrology Dialysis Transplantation Glomerular DiseaseRenal PathologyImmunologyRenal ScarringPathology	1994	138
Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I J. Haylor, Inderjit Singh, A. Meguid El Nahas Kidney International Molecular PhysiologyGrowth HormoneBiochemistryInhibitor Prevents VasodilationInsulin-like Growth Factor	1991	133
The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. Timothy S. Johnson, Martin Griffin, G Thomas, Journal of Clinical Investigation Glomerular DiseaseRenal PathologyImmunologyRenal InflammationPathology	1997	126
Transglutaminase Inhibition Reduces Fibrosis and Preserves Function in Experimental Chronic Kidney Disease Timothy S. Johnson, Marie Fisher, J. Haylor, Journal of the American Society of Nephrology	2007	123
Myofibroblasts and the progression of experimental glomerulonephritis. G Zhang, P.J. Moorhead, A. Meguid El Nahas PubMed Glomerular DiseaseRenal PathologyImmunologyRenal InflammationPathology	1995	117
Selective effect of low protein diets in chronic renal diseases. A. Meguid El Nahas, Anne Masters-Thomas, Sharon Brady, BMJ	1984	116

Page 1